MX2016000128A - Celulas de hongos filamentosos deficientes de o-manosiltransferasa y metodos de uso de las mismas. - Google Patents
Celulas de hongos filamentosos deficientes de o-manosiltransferasa y metodos de uso de las mismas.Info
- Publication number
- MX2016000128A MX2016000128A MX2016000128A MX2016000128A MX2016000128A MX 2016000128 A MX2016000128 A MX 2016000128A MX 2016000128 A MX2016000128 A MX 2016000128A MX 2016000128 A MX2016000128 A MX 2016000128A MX 2016000128 A MX2016000128 A MX 2016000128A
- Authority
- MX
- Mexico
- Prior art keywords
- filamentous fungal
- mutation
- mannosyltransferase
- fungal cell
- methods
- Prior art date
Links
- 230000002538 fungal effect Effects 0.000 title abstract 6
- 230000002950 deficient Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000035772 mutation Effects 0.000 abstract 4
- 241000223259 Trichoderma Species 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 241000123346 Chrysosporium Species 0.000 abstract 1
- 102000006722 Mannosyltransferases Human genes 0.000 abstract 1
- 108010087568 Mannosyltransferases Proteins 0.000 abstract 1
- 241000226677 Myceliophthora Species 0.000 abstract 1
- 241000221960 Neurospora Species 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 238000005621 mannosylation reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 101150053681 pmt gene Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01109—Dolichyl-phosphate-mannose-protein mannosyltransferase (2.4.1.109)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
Abstract
La presente descripción se refiere a composiciones y métodos útiles para la producción de proteínas heterólogas con O-manosilación reducida en células de hongos filamentosos, como células Trichoderma; más específicamente, la invención proporciona una célula de hongos filamentosos deficiente de PMT que comprende a) al menos una primera mutación que reduce una actividad de proteasa endógena en comparación con una célula de hongos filamentosos parentales que no tienen dicha primera mutación y, b) al menos una segunda mutación en un gen PMT que reduce la actividad endógena de 0-manosiltransferasa comparada con una célula de hongos filamentosos parentales que no tienen dicha segunda mutación, en donde dicha célula de hongos filamentosos es seleccionada del grupo consistente en células Trichoderma, Neurospora, Myceliophthora o Chrysosporium.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13175141 | 2013-07-04 | ||
| PCT/EP2014/064248 WO2015001049A1 (en) | 2013-07-04 | 2014-07-03 | O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016000128A true MX2016000128A (es) | 2016-03-01 |
| MX364532B MX364532B (es) | 2019-04-29 |
Family
ID=48740957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016000128A MX364532B (es) | 2013-07-04 | 2014-07-03 | Celulas de hongos filamentosos deficientes de o-manosiltransferasa y metodos de uso de las mismas. |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20160376570A1 (es) |
| EP (1) | EP3016970B1 (es) |
| KR (1) | KR102111078B1 (es) |
| CN (1) | CN105492457A (es) |
| BR (1) | BR112015032695A2 (es) |
| CA (1) | CA2916594C (es) |
| DK (1) | DK3016970T3 (es) |
| ES (1) | ES2739280T3 (es) |
| HR (1) | HRP20191069T1 (es) |
| MX (1) | MX364532B (es) |
| PL (1) | PL3016970T3 (es) |
| RU (1) | RU2016103373A (es) |
| SG (1) | SG11201510814YA (es) |
| SI (1) | SI3016970T1 (es) |
| WO (1) | WO2015001049A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108064266A (zh) | 2014-07-21 | 2018-05-22 | 格利科斯芬兰公司 | 在丝状真菌中具有哺乳动物样n-聚糖的糖蛋白的制备 |
| US20210388310A1 (en) * | 2018-09-20 | 2021-12-16 | Perfect Day, Inc. | Methods and compositions for producing homokaryotic filamentous fungal cells |
| WO2020112881A1 (en) * | 2018-11-28 | 2020-06-04 | Novozymes A/S | Modified filamentous fungal host cells |
| CN110885810B (zh) * | 2019-12-16 | 2021-03-23 | 华中农业大学 | 一种利用真核发酵制备得到的抑菌蛋白酶CmYC1及其应用 |
| CN115976033B (zh) * | 2022-12-14 | 2024-05-17 | 西南大学 | 瓜实蝇tssk1和tssk3基因及其应用 |
| WO2025005761A1 (ko) * | 2023-06-29 | 2025-01-02 | 씨제이제일제당 (주) | 아스파르트산 프로테아제 변이체 |
| CN119931997B (zh) * | 2025-04-09 | 2025-07-25 | 安琪酵母股份有限公司 | 天冬氨酸蛋白酶突变体及其应用 |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4743546A (en) | 1985-02-13 | 1988-05-10 | Biotechnica International, Inc. | Controlled gene excision |
| GB2276169A (en) | 1990-07-05 | 1994-09-21 | Celltech Ltd | Antibodies specific for carcinoembryonic antigen |
| DE4244915C2 (de) | 1992-08-14 | 1998-12-03 | Widmar Prof Dr Tanner | DNA-Moleküle codierend Proteine, die an der O-Glykosylierung von Proteinen beteiligt sind |
| EP0966521A1 (en) | 1996-09-13 | 1999-12-29 | Novo Nordisk Biotech, Inc. | Cells having dna insertion mutations which produce altered amounts of a polypeptide |
| DE19754622A1 (de) | 1997-12-09 | 1999-06-10 | Antje Von Dr Schaewen | Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität |
| GB9902000D0 (en) | 1999-01-30 | 1999-03-17 | Delta Biotechnology Ltd | Process |
| GB0021421D0 (en) | 2000-08-31 | 2000-10-18 | Oxford Glycosciences Uk Ltd | Compounds |
| CN1592786A (zh) | 2000-12-05 | 2005-03-09 | 宾夕法尼亚州立研究基金会 | 在酵母菌中高效生产异源性蛋白质的方法和组合物 |
| WO2005003296A2 (en) | 2003-01-22 | 2005-01-13 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| WO2004057007A1 (en) | 2002-12-20 | 2004-07-08 | Unilever Plc | Preparation of antifreeze protein |
| EP1704164B1 (en) | 2003-12-03 | 2011-12-28 | Kröz, Monika | Interleukin-11 fusion proteins |
| JP5010923B2 (ja) | 2004-02-09 | 2012-08-29 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | アルブミン融合蛋白質 |
| WO2006036817A2 (en) | 2004-09-24 | 2006-04-06 | Microbia, Inc. | Fungal variants and uses thereof |
| DK1941025T3 (da) * | 2005-10-17 | 2011-09-26 | Novozymes As | Brug af svampemutanter til ekspression af antistoffer |
| ES2534465T3 (es) * | 2005-11-15 | 2015-04-23 | Glycofi, Inc. | Producción de glucoproteínas con O-glucosilación reducida |
| ES2553162T3 (es) | 2006-05-16 | 2015-12-04 | Daiichi Sankyo Company, Limited | Método de producción de alta secreción de proteínas |
| EP2102366A4 (en) | 2006-12-10 | 2010-01-27 | Dyadic International Inc | EXPRESSION AND HIGH-DROP SCREENING OF COMPLEX EXPRESSED DNA LIBRARIES IN FADENED MUSHROOMS |
| GB0711424D0 (en) | 2007-06-13 | 2007-07-25 | Novozymes Delta Ltd | Recombinant transferrin mutants |
| US20110124576A1 (en) | 2007-08-08 | 2011-05-26 | Novozymes A/S | Transferrin Variants and Conjugates |
| CA2714166A1 (en) * | 2008-02-20 | 2009-08-27 | Glycofi, Inc. | Vectors and yeast strains for protein production |
| US20090253173A1 (en) * | 2008-04-08 | 2009-10-08 | Danisco Us Inc., Genencor Division | Filamentous fungi with inactivated protease genes for altered protein production |
| WO2009143041A1 (en) | 2008-05-20 | 2009-11-26 | Merck & Co., Inc. | Efficient production of heterologous proteins using mannosyl transferase inhibitors |
| WO2010019487A1 (en) * | 2008-08-12 | 2010-02-18 | Glycofi, Inc. | Improved vectors and yeast strains for protein production: ca2+ atpase overexpression |
| WO2010034708A1 (en) | 2008-09-23 | 2010-04-01 | Unilever Plc | A polynucleotide expression cassette |
| KR101722961B1 (ko) | 2009-02-11 | 2017-04-04 | 알부메딕스 에이/에스 | 알부민 변이체 및 접합체 |
| WO2010128143A1 (en) | 2009-05-07 | 2010-11-11 | Novozymes Biopharma Dk A/S | Method of controlling o-linked glycosylation of antibodies |
| SG175716A1 (en) | 2009-05-07 | 2011-12-29 | Novozymes Biopharma Dk As | Method of controlling o-linked glycosylation of antibodies |
| US8440456B2 (en) | 2009-05-22 | 2013-05-14 | Vib, Vzw | Nucleic acids of Pichia pastoris and use thereof for recombinant production of proteins |
| MX2012004381A (es) | 2009-10-16 | 2012-06-01 | Merck Sharp & Dohme | Metodo para producir proteinas en pichia pastoris que carecen de actividad de entrelazamiento detectable con anticuerpos contra antigenos de la celula hospedera. |
| EP3000871A1 (en) | 2009-12-18 | 2016-03-30 | Novozymes, Inc. | Methods for producing polypeptides in protease-deficient mutants of trichoderma |
| EP2534255B1 (en) | 2010-02-10 | 2017-05-10 | Biocon Limited | Method of reducing glycosylation of proteins, processes and proteins thereof |
| RU2012140429A (ru) | 2010-02-24 | 2014-03-27 | Мерк Шарп Энд Домэ Корп. | Способ увеличения занятости участков n-ликозилирования на терапевтических гликопротеинах, продуцируемых в p pastoris |
| RU2604811C2 (ru) | 2010-05-27 | 2016-12-10 | Мерк Шарп Энд Домэ Корп. | Способ получения антител с улучшенными свойствами |
| US20120135461A1 (en) | 2010-07-30 | 2012-05-31 | William James Cook | Production of glycoproteins with reduced o-glycosylation comprising the use of an alpha-1,2-mannosidase |
| JP6017439B2 (ja) | 2010-11-24 | 2016-11-02 | ノバルティス・インターナショナル・ファーマシューティカル・リミテッドNovartis International Pharmaceutical Ltd. | N−アセチルグルコサミニルトランスフェラーゼ活性を有する融合酵素 |
| JP5885191B2 (ja) | 2011-01-04 | 2016-03-15 | 国立研究開発法人産業技術総合研究所 | 糖鎖改変酵母及びそれを用いた糖タンパク質の製造方法 |
| CN103764837A (zh) | 2011-02-25 | 2014-04-30 | 默沙东公司 | 用于生产具有修饰的o-糖基化的蛋白的酵母菌株 |
| US9328170B2 (en) | 2011-05-25 | 2016-05-03 | Merck Sharp & Dohme Corp. | Method for preparing Fc containing polypeptides having improved properties |
| AR087433A1 (es) | 2011-08-08 | 2014-03-26 | Merck Sharp & Dohme | Analogos de insulina n-glicosilados |
| US20140302556A1 (en) | 2011-10-27 | 2014-10-09 | Merck Sharp & Doheme Corp. | Controlling o-glycosylation in lower eukaryotes |
| IN2014CN03072A (es) | 2011-10-31 | 2015-07-31 | Merck Sharp & Dohme | |
| WO2013066765A1 (en) | 2011-11-01 | 2013-05-10 | Merck Sharp & Dohme Corp. | Mutation of tup1 in glycoengineered yeast |
| EP2780463A4 (en) | 2011-11-18 | 2015-07-01 | Merck Sharp & Dohme | FC-CONTAINING POLYPEPTIDES WITH INCREASED INFLAMMATORY FEATURES AND INCREASED FCRN BINDING |
| US9695454B2 (en) | 2012-05-23 | 2017-07-04 | Glykos Finland Oy | Production of fucosylated glycoproteins |
| US20150275222A1 (en) | 2012-10-22 | 2015-10-01 | Bo Jiang | Crz1 mutant fungal cells |
| AU2013363266A1 (en) | 2012-12-17 | 2015-05-07 | Merck Sharp & Dohme Corp. | pmt2, och1, pmt5 Mutant Cells |
| WO2014126787A1 (en) | 2013-02-13 | 2014-08-21 | Merck Sharp & Dohme Corp. | Methods for increasing n-glycan occupancy and reducing production of hybrid n-glycans in pichia pastoris strains lacking alg3 expression |
| ES2843679T3 (es) | 2013-03-06 | 2021-07-20 | Glaxosmithkline Llc | Células hospedadoras y métodos de uso |
| US20160207978A1 (en) | 2013-05-06 | 2016-07-21 | Cell Machines Inc. | Methods and compositions related to large scale production of proteins |
| US20160115216A1 (en) | 2013-06-07 | 2016-04-28 | Novo Nordisk A/S | Method for Making Mature Insulin Polypeptides |
| WO2015013116A1 (en) | 2013-07-25 | 2015-01-29 | Merck Sharp & Dohme Corp. | Method for reducing the extent of o-mannosylation of glycoproteins |
| US20160215061A1 (en) | 2013-10-08 | 2016-07-28 | Merck Sharp & Dohme Corp. | Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO FcGammaRIIB |
| WO2015073307A2 (en) | 2013-11-13 | 2015-05-21 | Merck Sharp & Dohme Corp. | Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO HUMAN DC-SIGN |
-
2014
- 2014-07-03 EP EP14734515.1A patent/EP3016970B1/en active Active
- 2014-07-03 HR HRP20191069 patent/HRP20191069T1/hr unknown
- 2014-07-03 KR KR1020157036975A patent/KR102111078B1/ko active Active
- 2014-07-03 WO PCT/EP2014/064248 patent/WO2015001049A1/en not_active Ceased
- 2014-07-03 US US14/902,492 patent/US20160376570A1/en not_active Abandoned
- 2014-07-03 RU RU2016103373A patent/RU2016103373A/ru not_active Application Discontinuation
- 2014-07-03 CA CA2916594A patent/CA2916594C/en active Active
- 2014-07-03 SI SI201431239T patent/SI3016970T1/sl unknown
- 2014-07-03 BR BR112015032695A patent/BR112015032695A2/pt not_active Application Discontinuation
- 2014-07-03 CN CN201480048205.5A patent/CN105492457A/zh active Pending
- 2014-07-03 DK DK14734515.1T patent/DK3016970T3/da active
- 2014-07-03 PL PL14734515T patent/PL3016970T3/pl unknown
- 2014-07-03 ES ES14734515T patent/ES2739280T3/es active Active
- 2014-07-03 MX MX2016000128A patent/MX364532B/es active IP Right Grant
- 2014-07-03 SG SG11201510814YA patent/SG11201510814YA/en unknown
-
2018
- 2018-09-07 US US16/124,679 patent/US10724013B2/en active Active
-
2020
- 2020-06-15 US US16/901,175 patent/US20200362319A1/en not_active Abandoned
-
2022
- 2022-03-21 US US17/699,302 patent/US20220213451A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20220213451A1 (en) | 2022-07-07 |
| EP3016970A1 (en) | 2016-05-11 |
| KR102111078B1 (ko) | 2020-05-18 |
| US20160376570A1 (en) | 2016-12-29 |
| DK3016970T3 (da) | 2019-06-24 |
| CN105492457A (zh) | 2016-04-13 |
| US20200040314A1 (en) | 2020-02-06 |
| US20200362319A1 (en) | 2020-11-19 |
| PL3016970T3 (pl) | 2019-09-30 |
| BR112015032695A2 (pt) | 2017-10-24 |
| RU2016103373A (ru) | 2017-08-10 |
| KR20160030127A (ko) | 2016-03-16 |
| EP3016970B1 (en) | 2019-05-22 |
| US10724013B2 (en) | 2020-07-28 |
| SI3016970T1 (sl) | 2019-08-30 |
| WO2015001049A1 (en) | 2015-01-08 |
| MX364532B (es) | 2019-04-29 |
| SG11201510814YA (en) | 2016-01-28 |
| ES2739280T3 (es) | 2020-01-30 |
| CA2916594A1 (en) | 2015-01-08 |
| RU2016103373A3 (es) | 2018-03-26 |
| CA2916594C (en) | 2020-03-10 |
| HRP20191069T1 (hr) | 2019-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX364532B (es) | Celulas de hongos filamentosos deficientes de o-manosiltransferasa y metodos de uso de las mismas. | |
| MX2016000306A (es) | Celulas de hongos filamentosos deficientes en multiples proteasas y métodos de uso de las mismas. | |
| MX2014008272A (es) | Celulas de hongos filamentosas deficientes de proteasa y metodos de uso de las mismas. | |
| MX363788B (es) | Métodos para la producción de polipéptidos procesados proteolíticamente. | |
| MX2023011785A (es) | Metodos y composiciones para produccion de proteina de clara de huevo. | |
| MX2016016903A (es) | Animales no humanos que tienen un gen de muerte celular programada 1 humanizado. | |
| WO2016057951A3 (en) | Crispr oligonucleotides and gene editing | |
| EP3957711A3 (en) | Detergent composition comprising amylase and protease variants | |
| WO2015200920A8 (en) | Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof | |
| EA201591294A1 (ru) | Рекомбинантный микроорганизм для применения в способе с повышенным выходом продукта | |
| MX2019003427A (es) | Composiciones para cultivo celular y metodos para la produccion de polipeptidos. | |
| MX2017000083A (es) | Compuestos de platino, composiciones y usos de estos. | |
| MX390701B (es) | Manufactura de proteína. | |
| EP4502167A3 (en) | N-glycosylation | |
| WO2013188469A3 (en) | Pathways characterization of cells | |
| MX2016015893A (es) | Produccion de fragmentos de fragmento cristalizable (fc). | |
| MY182924A (en) | Enzyme compositions and uses thereof | |
| MX2015011781A (es) | Medio de cultivo celular y metodos de produccion de anticuerpos. | |
| MX2022000425A (es) | Metodos y composiciones que comprenden un nivel reducido de proteinas de celulas hospedadoras. | |
| TW201613974A (en) | Tumor-selective CTLA-4 antagonists | |
| MX2015013447A (es) | Polipeptidos que tienen actividad de la fosfolipasa a y polinucleotidos que los codifican. | |
| WO2014182684A3 (en) | Methods and compositions related to large scale production of proteins | |
| MX2020001223A (es) | Proteinas de fusion tatk-cdkl5, composiciones, formulaciones y uso de estas. | |
| HK1255078A1 (zh) | 细胞效能分析 | |
| PH12016502604A1 (en) | Aglycosylated enzyme and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: GLYKOS FINLAND OY |
|
| FG | Grant or registration |